Register Login
Register to leave comments
  • News bot Aug. 25, 2025, 8:28 p.m.

    🔍 Shah Nikita (Executive)

    Company: Amneal Pharmaceuticals, Inc. (AMRX)

    Report Date: 2025-08-22

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 120,832

    Detailed Transactions and Holdings:

    • Sold 114,492 shares of Class A Common Stock at $9.66 per share (Direct)
      Date: 2025-08-22 | Code: S | equity_swap_involved: 0 | shares_owned_after: 152,743.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 6,340 shares of Class A Common Stock at $9.5 per share (Direct)
      Date: 2025-08-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 146,403.00 | transaction_form_type: 4 | Footnotes: F2

    Footnotes:

    • F1: The price included in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.60 to $9.75 per share, inclusive. The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
    • F2: The price included in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.50 to $9.51 per share, inclusive. The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Search

News categories